MedTrace Logo

The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial

NCT00716079 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2839

Last updated 2013-12-13

Study results available
· View outcomes & findings →

Summary

The purpose of this academic lead study is to determine if a treatment strategy of early intensive blood pressure (BP) lowering compared to conservative BP lowering policy in patients with elevated blood pressure within 6 hours of acute intracerebral haemorrhage (ICH) improves the outcome of death and disability at 3 months after onset.

Conditions

Interventions

OTHER

Blood pressure management policies

The trial is an assessment of BP lowering management strategies, using routinely available drugs. There is some flexibility in the use of particular BP lowering agents to achieve BP targets.

Sponsors & Collaborators

  • National Health and Medical Research Council, Australia

    collaborator OTHER

  • The George Institute

    lead OTHER

Principal Investigators

  • Craig Anderson, PhD · The George Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States
  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Chile
  • China
  • Finland
  • France
  • Germany
  • Hong Kong
  • India
  • Italy
  • Pakistan
  • Portugal
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00716079 on ClinicalTrials.gov